AF
BMRN icon

Allworth Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Allworth Financial’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
5,963
-1,635
-22% -$89.6K ﹤0.01% 1187
2026
Q1 		$429K Buy
7,598
+2,508
+49% +$146K ﹤0.01% 1017
2025
Q4 		$302K Buy
5,090
+889
+21% +$48.4K ﹤0.01% 1150
2025
Q3 		$228K Buy
4,201
+1,557
+59% +$89K ﹤0.01% 1243
2025
Q2 		$145K Buy
2,644
+851
+47% +$50.1K ﹤0.01% 1335
2025
Q1 		$112K Sell
1,793
-111
-6% -$7.47K ﹤0.01% 1174
2024
Q4 		$118K Buy
1,904
+127
+7% +$8.51K ﹤0.01% 1185
2024
Q3 		$125K Sell
1,777
-191
-10% -$16K ﹤0.01% 985
2024
Q2 		$165K Buy
1,968
+4
+0.2% +$333 ﹤0.01% 880
2024
Q1 		$172K Buy
1,964
+1,360
+225% +$122K ﹤0.01% 828
2023
Q4 		$58.2K Buy
604
+214
+55% +$18.9K ﹤0.01% 1143
2023
Q3 		$34.5K Buy
390
+44
+13% +$3.92K ﹤0.01% 1260
2023
Q2 		$30K Sell
346
-10
-3% -$941 ﹤0.01% 1320
2023
Q1 		$34.6K Buy
356
+130
+58% +$13.5K ﹤0.01% 1213
2022
Q4 		$23.4K Buy
226
+27
+14% +$2.54K ﹤0.01% 1290
2022
Q3 		$17K Buy
199
+39
+24% +$3.47K ﹤0.01% 1358
2022
Q2 		$13K Sell
160
-102
-39% -$8.12K ﹤0.01% 1428
2022
Q1 		$20K Hold
262
– – ﹤0.01% 1255
2021
Q4 		$23K Hold
262
– – ﹤0.01% 1057
2021
Q3 		$20K Buy
262
+126
+93% +$9.94K ﹤0.01% 1023
2021
Q2 		$11K Sell
136
-25
-16% -$1.98K ﹤0.01% 1009
2021
Q1 		$12K Buy
161
+21
+15% +$1.72K ﹤0.01% 927
2020
Q4 		$12K Hold
140
– – ﹤0.01% 782
2020
Q3 		$11K Buy
140
+25
+22% +$2.53K ﹤0.01% 684
2020
Q2 		$14K Hold
115
– – ﹤0.01% 651
2020
Q1 		$10K Hold
115
– – ﹤0.01% 693
2019
Q4 		$10K Buy
+115
New +$8.69K ﹤0.01% 642

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Allworth Financial's BMRN Position: Q2 2026 in Review

Allworth Financial reduced its BioMarin Pharmaceuticals (BMRN) stake by 22% in Q2 2026, selling an estimated $89.6K and leaving 5,963 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

Allworth Financial first reported a position in BMRN in Q4 2019 and has held it in 27 quarters since. The position peaked at $429K in Q1 2026. 562 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Allworth Financial held 5,963 shares of BioMarin Pharmaceuticals worth $341K as of Q2 2026.
  • Allworth Financial sold 1,635 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $89.6K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1187 holding.
  • Allworth Financial first reported a position in BioMarin Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Allworth Financial's BioMarin Pharmaceuticals position peaked at $429K in Q1 2026.
  • 562 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.